HSBC Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $239M | Buy |
382,028
+58,690
| +18% | +$39.9M | 0.1% | 183 |
|
|
2026
Q1 | $250M | Buy |
323,338
+4,530
| +1% | +$3.47M | 0.13% | 148 |
|
|
2025
Q4 | $246M | Sell |
318,808
-51,157
| -14% | -$34.7M | 0.13% | 147 |
|
|
2025
Q3 | $208M | Buy |
369,965
+7,841
| +2% | +$4.43M | 0.12% | 163 |
|
|
2025
Q2 | $190M | Sell |
362,124
-27,474
| -7% | -$15.3M | 0.11% | 164 |
|
|
2025
Q1 | $247M | Sell |
389,598
-44,206
| -10% | -$30.4M | 0.15% | 125 |
|
|
2024
Q4 | $309M | Buy |
433,804
+76,720
| +21% | +$64.4M | 0.18% | 91 |
|
|
2024
Q3 | $375M | Sell |
357,084
-8,841
| -2% | -$9.84M | 0.22% | 76 |
|
|
2024
Q2 | $384M | Sell |
365,925
-11,501
| -3% | -$11.1M | 0.23% | 74 |
|
|
2024
Q1 | $363M | Buy |
377,426
+52,414
| +16% | +$49.8M | 0.25% | 72 |
|
|
2023
Q4 | $286M | Buy |
325,012
+56,010
| +21% | +$46.1M | 0.25% | 66 |
|
|
2023
Q3 | $221M | Sell |
269,002
-33,661
| -11% | -$26.5M | 0.23% | 71 |
|
|
2023
Q2 | $217M | Buy |
302,663
+46,863
| +18% | +$36.1M | 0.22% | 82 |
|
|
2023
Q1 | $210M | Sell |
255,800
-1,805
| -0.7% | -$1.36M | 0.25% | 72 |
|
|
2022
Q4 | $186M | Buy |
257,605
+71,846
| +39% | +$53M | 0.21% | 86 |
|
|
2022
Q3 | $128M | Buy |
185,759
+28,396
| +18% | +$17.9M | 0.21% | 84 |
|
|
2022
Q2 | $93.5M | Buy |
157,363
+66,224
| +73% | +$43M | 0.13% | 133 |
|
|
2022
Q1 | $63.5M | Sell |
91,139
-5,791
| -6% | -$3.66M | 0.08% | 251 |
|
|
2021
Q4 | $61.8M | Sell |
96,930
-22,829
| -19% | -$14M | 0.06% | 326 |
|
|
2021
Q3 | $72.6M | Sell |
119,759
-11,919
| -9% | -$7.4M | 0.07% | 237 |
|
|
2021
Q2 | $73M | Sell |
131,678
-134,728
| -51% | -$68.3M | 0.08% | 239 |
|
|
2021
Q1 | $126M | Buy |
266,406
+139,352
| +110% | +$67.8M | 0.15% | 137 |
|
|
2020
Q4 | $60.9M | Buy |
127,054
+48,443
| +62% | +$26.1M | 0.08% | 233 |
|
|
2020
Q3 | $44.7M | Buy |
78,611
+3,255
| +4% | +$1.97M | 0.07% | 260 |
|
|
2020
Q2 | $47M | Buy |
75,356
+4,657
| +7% | +$2.64M | 0.09% | 203 |
|
|
2020
Q1 | $34.1M | Sell |
70,699
-18,539
| -21% | -$7.65M | 0.08% | 235 |
|
|
2019
Q4 | $33.4M | Sell |
89,238
-6,303
| -7% | -$2.12M | 0.06% | 336 |
|
|
2019
Q3 | $26.5M | Buy |
95,541
+10,310
| +12% | +$3.05M | 0.05% | 433 |
|
|
2019
Q2 | $26.7M | Buy |
85,231
+27,064
| +47% | +$9.01M | 0.05% | 393 |
|
|
2019
Q1 | $23.9M | Buy |
58,167
+5,895
| +11% | +$2.43M | 0.04% | 445 |
|
|
2018
Q4 | $19.5M | Sell |
52,272
-7,190
| -12% | -$2.63M | 0.04% | 508 |
|
|
2018
Q3 | $24M | Buy |
59,462
+13,914
| +31% | +$5.3M | 0.04% | 486 |
|
|
2018
Q2 | $15.7M | Sell |
45,548
-26,891
| -37% | -$8.41M | 0.03% | 604 |
|
|
2018
Q1 | $24.9M | Sell |
72,439
-79,994
| -52% | -$27.8M | 0.04% | 460 |
|
|
2017
Q4 | $57.3M | Buy |
152,433
+107,783
| +241% | +$43.7M | 0.08% | 217 |
|
|
2017
Q3 | $20M | Sell |
44,650
-17,998
| -29% | -$8.56M | 0.03% | 546 |
|
|
2017
Q2 | $30.8M | Sell |
62,648
-623
| -1% | -$273K | 0.06% | 359 |
|
|
2017
Q1 | $24.5M | Sell |
63,271
-1,261
| -2% | -$467K | 0.05% | 414 |
|
|
2016
Q4 | $23.7M | Buy |
64,532
+10,406
| +19% | +$3.96M | 0.06% | 421 |
|
|
2016
Q3 | $21.8M | Buy |
54,126
+7,822
| +17% | +$3.14M | 0.05% | 402 |
|
|
2016
Q2 | $16.2M | Sell |
46,304
-7,522
| -14% | -$2.9M | 0.04% | 483 |
|
|
2016
Q1 | $19.4M | Buy |
53,826
+1,991
| +4% | +$820K | 0.05% | 421 |
|
|
2015
Q4 | $28.2M | Sell |
51,835
-15,202
| -23% | -$8.24M | 0.07% | 332 |
|
|
2015
Q3 | $31.1M | Sell |
67,037
-29,335
| -30% | -$15.8M | 0.08% | 286 |
|
|
2015
Q2 | $49.1M | Sell |
96,372
-1,378
| -1% | -$672K | 0.1% | 212 |
|
|
2015
Q1 | $44.2M | Buy |
97,750
+9,700
| +11% | +$4.11M | 0.08% | 248 |
|
|
2014
Q4 | $36.1M | Buy |
88,050
+17,850
| +25% | +$7.02M | 0.07% | 280 |
|
|
2014
Q3 | $25.3M | Buy |
70,200
+11,199
| +19% | +$3.75M | 0.05% | 368 |
|
|
2014
Q2 | $16.6M | Sell |
59,001
-16,284
| -22% | -$4.83M | 0.04% | 461 |
|
|
2014
Q1 | $22.6M | Buy |
75,285
+11,973
| +19% | +$3.69M | 0.05% | 356 |
|
|
2013
Q4 | $17.4M | Buy |
63,312
+14,089
| +29% | +$4.05M | 0.05% | 443 |
|
|
2013
Q3 | $15.3M | Buy |
49,223
+14,998
| +44% | +$3.94M | 0.04% | 462 |
|
|
2013
Q2 | $7.7M | Buy |
+34,225
| New | +$7.97M | 0.02% | 578 |
|
Other funds holding REGN
HSBC Holdings's REGN Position: Q2 2026 in Review
HSBC Holdings increased its Regeneron Pharmaceuticals (REGN) stake by 18% in Q2 2026, buying an estimated $39.9M and bringing the position to 382,028 shares worth $239M. The position accounts for 0.1% of the portfolio, ranked #183.
HSBC Holdings first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $384M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- HSBC Holdings held 382,028 shares of Regeneron Pharmaceuticals worth $239M as of Q2 2026.
- HSBC Holdings bought 58,690 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $39.9M.
- Regeneron Pharmaceuticals made up 0.1% of HSBC Holdings's portfolio in Q2 2026, its #183 holding.
- HSBC Holdings first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- HSBC Holdings's Regeneron Pharmaceuticals position peaked at $384M in Q2 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.